
    
      Primary endpoint: Fugl-Meyer Upper Extremity (FM-UE) Secondary endpoints: Box and Block Test
      (BBT), Modified Ashworth Scale (MAS); motor cortex excitability (TMS); Electromyography
      analysis of muscle activation patterns during upper extremity movements; measurements of
      cerebral perfusion (NIRS); circulating biomarkers (see Figure 3 and Table 1). Overall
      assessments will be performed pre-, mid-, post-treatment and at 6-months follow-up.
    
  